02/03/2026 13:04
|
Medical, Health & Aged Care
Alexion, AstraZeneca Rare Disease’s Ultomiris® (ravulizumab rch) has been listed on the Pharmaceutical Benefits Scheme (PBS) for adults with generalised myasthenia gravis (gMG) who are...